• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors associated with depressive symptoms in patients with benign prostatic enlargement.与良性前列腺增生患者抑郁症状相关的因素。
Afr J Prim Health Care Fam Med. 2023 May 22;15(1):e1-e7. doi: 10.4102/phcfm.v15i1.3572.
2
Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.中心性肥胖可预测良性前列腺增生手术后持续性下尿路症状(LUTS)的发生:一项多中心前瞻性研究的结果
BJU Int. 2015 Aug;116(2):271-7. doi: 10.1111/bju.13038. Epub 2015 Apr 20.
3
Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study.仅依靠国际前列腺症状评分能否调查与良性前列腺增生相关的下尿路症状男性的储尿症状?一项横断面研究的结果。
Eur Urol Focus. 2022 Mar;8(2):555-562. doi: 10.1016/j.euf.2021.03.004. Epub 2021 Mar 20.
4
Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression.了解有进展风险的前列腺增大男性个体特征中的治疗反应。
Eur Urol Focus. 2023 Jan;9(1):178-187. doi: 10.1016/j.euf.2022.07.004. Epub 2022 Aug 18.
5
Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.下尿路症状与血清5-羟色胺水平低、脂联素和空腹血糖水平高以及良性前列腺增生有关。
Scand J Urol. 2015 Apr;49(2):155-61. doi: 10.3109/21681805.2014.936495. Epub 2014 Sep 25.
6
The Investigation of Relationship between Coronary Artery Ectasia, Benign Prostatic Enlargement, and Lower Urinary Tract Symptoms.冠状动脉扩张、良性前列腺增生与下尿路症状之间关系的研究
Urology. 2015 Jun;85(6):1436-40. doi: 10.1016/j.urology.2015.02.031. Epub 2015 Apr 9.
7
Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.良性前列腺增生患者的代谢综合征与下尿路症状:与储尿期症状的可能联系
Urology. 2014 Nov;84(5):1181-7. doi: 10.1016/j.urology.2014.07.018. Epub 2014 Oct 24.
8
Moderate-to-high cardiovascular risk is associated with increased lower urinary tract storage symptoms in patients with benign prostatic enlargement.中到高度心血管风险与良性前列腺增生患者下尿路储尿期症状增加相关。
Minerva Urol Nefrol. 2018 Jun;70(3):340-346. doi: 10.23736/S0393-2249.18.03107-7. Epub 2018 Feb 22.
9
Incidence of Nocturia in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement and Outcomes After Medical Treatment: Results from the Evolution European Association of Urology Research Foundation Prospective Multinational Registry.良性前列腺增生相关下尿路症状男性夜尿症的发生率和药物治疗后的结局:来自欧洲泌尿外科学会研究基金会进化前瞻性多国注册研究的结果。
Eur Urol Focus. 2021 Jan;7(1):178-185. doi: 10.1016/j.euf.2019.07.003. Epub 2019 Jul 23.
10
Is there any Relationship between Total Prostate Volume, Intravesical Prostatic Protrusion and Lower Urinary Tract Symptoms in Adult Nigerian Men with Benign Prostatic Enlargement?成年尼日利亚男性良性前列腺增生患者的前列腺总体积、膀胱内前列腺突入与下尿路症状之间是否存在关系?
West Afr J Med. 2021 Jun 26;38(6):578-582.

本文引用的文献

1
Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis.5α还原酶抑制剂用药后抑郁风险:荟萃分析
World J Mens Health. 2020 Oct;38(4):535-544. doi: 10.5534/wjmh.190046. Epub 2019 May 23.
2
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
3
Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis.患者健康问卷-9(PHQ-9)筛查检测主要抑郁症的准确性:个体参与者数据荟萃分析。
BMJ. 2019 Apr 9;365:l1476. doi: 10.1136/bmj.l1476.
4
A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome.关于5α还原酶抑制剂的美国食品药品监督管理局不良事件报告系统(FAERS)数据综述:对非那雄胺后综合征的启示
Urology. 2018 Oct;120:143-149. doi: 10.1016/j.urology.2018.06.022. Epub 2018 Jun 27.
5
Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction.下尿路症状/良性前列腺增生与勃起功能障碍的流行病学及危险因素
Aging Male. 2019 Mar;22(1):12-19. doi: 10.1080/13685538.2018.1434772. Epub 2018 Feb 2.
6
Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE.睡眠问题与下尿路症状的发展和进展有关:RE- DUC 的研究结果。
J Urol. 2018 Feb;199(2):536-542. doi: 10.1016/j.juro.2017.08.108. Epub 2017 Sep 1.
7
Association of Suicidality and Depression With 5α-Reductase Inhibitors.自杀倾向及抑郁与5α-还原酶抑制剂的关联
JAMA Intern Med. 2017 May 1;177(5):683-691. doi: 10.1001/jamainternmed.2017.0089.
8
Diagnostic Work-Up of Lower Urinary Tract Symptoms.
Urol Clin North Am. 2016 Aug;43(3):299-309. doi: 10.1016/j.ucl.2016.04.002.
9
The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.与下尿路症状相关的良性前列腺增生症的流行病学:患病率和发病率
Urol Clin North Am. 2016 Aug;43(3):289-97. doi: 10.1016/j.ucl.2016.04.001.
10
Relationship Between Depression and Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.抑郁症与良性前列腺增生继发的下尿路症状之间的关系。
Rev Urol. 2015;17(2):51-7. doi: 10.3909/riu0658.

与良性前列腺增生患者抑郁症状相关的因素。

Factors associated with depressive symptoms in patients with benign prostatic enlargement.

机构信息

Department of Family Medicine, Aga Khan University, Nairobi.

出版信息

Afr J Prim Health Care Fam Med. 2023 May 22;15(1):e1-e7. doi: 10.4102/phcfm.v15i1.3572.

DOI:10.4102/phcfm.v15i1.3572
PMID:37265158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10244931/
Abstract

BACKGROUND

Depression is a common condition that may lead to suicide at its worst. It is considered one of the primary causes of morbidity globally. Among the urological causes of depression is benign prostatic enlargement (BPE).

AIM

To determine the prevalence and factors associated with depressive symptoms among BPE patients.

SETTING

This study was conducted in the Urology and Family Medicine Clinic at the Aga Khan University Hospital, Nairobi and Urology clinic at the Aga Khan Hospital Mombasa.

METHODS

The study was a cross-sectional design recruiting 308 males above the age of 40. Patient Health Questionnaire-9 and International Prostate Symptom Score (IPSS) were used to assess depressive symptoms and lower urinary tract symptoms (LUTS), respectively. Association between depressive symptoms and LUTS was determined. Factors associated with depressive symptoms were analysed by logistic regression.

RESULTS

Prevalence of depressive symptoms among patients with symptomatic benign prostatic enlargement (sBPE) was 42.90%. Factors associated with depressive symptoms included comorbid conditions, medication side effects, reduced libido, alcohol use, disturbed sleep at night and anxiety in regard to the prostate condition.

CONCLUSION

There is a high prevalence of depressive symptoms among men with BPE. Assessment and early intervention for depressive symptoms among men with BPE should be initiated before clinical depression sets in.Contribution: The study has created a knowledge base on factors associated with depressive symptoms among men with sBPE in the African context.

摘要

背景

抑郁症是一种常见的疾病,严重时可能导致自杀。它被认为是全球发病率的主要原因之一。导致抑郁症的泌尿系统原因之一是良性前列腺增生(BPE)。

目的

确定 BPE 患者中抑郁症状的患病率和相关因素。

地点

本研究在肯尼亚内罗毕的 Aga Khan 大学医院泌尿科和家庭医学诊所以及蒙巴萨的 Aga Khan 医院泌尿科进行。

方法

这是一项横断面研究,招募了 308 名年龄在 40 岁以上的男性。使用患者健康问卷-9(PHQ-9)和国际前列腺症状评分(IPSS)分别评估抑郁症状和下尿路症状(LUTS)。确定抑郁症状与 LUTS 之间的关联。使用逻辑回归分析与抑郁症状相关的因素。

结果

有症状的良性前列腺增生(sBPE)患者中抑郁症状的患病率为 42.90%。与抑郁症状相关的因素包括合并症、药物副作用、性欲减退、饮酒、夜间睡眠紊乱以及对前列腺状况的焦虑。

结论

BPE 男性中抑郁症状的患病率很高。应在临床抑郁症发生之前,对 BPE 男性进行抑郁症状的评估和早期干预。

贡献

该研究在非洲背景下创建了一个与 sBPE 男性抑郁症状相关因素的知识库。